Novel avenues of tau research.
Autor: | Sexton CE; Alzheimer's Association, Chicago, Illinois, USA., Bitan G; Department of Neurology, David Geffen School of Medicine, Brain Research Institute, Molecular Biology Institute, University of California Los Angeles (UCLA), Los Angeles, California, USA., Bowles KR; UK Dementia Research Institute at the University of Edinburgh, Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK., Brys M; Eli Lilly & Co., Indianapolis, Indiana, USA., Buée L; Univ Lille, Inserm, CHU-Lille, Lille Neuroscience and Cognition, LabEx DISTALZ, Place de Verdun, Lille, France., Maina MB; Sussex Neuroscience, School of Life Sciences, University of Sussex, Falmer, UK.; Biomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria., Clelland CD; Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA., Cohen AD; University of Pittsburgh, School of Medicine, Department of Psychiatry and Alzheimer's disease Research Center, Pittsburgh, Pennsylvania, USA., Crary JF; Departments of Pathology, Neuroscience, and Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Dage JL; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Diaz K; CurePSP, Inc, New York, New York, USA., Frost B; Sam & Ann Barshop Institute for Longevity & Aging Studies Glenn Biggs Institute for Alzheimer's & Neurodegenerative Disorders Department of Cell Systems and Anatomy University of Texas Health San Antonio, San Antonio, Texas, USA., Gan L; Helen and Robert Appel Alzheimer Disease Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA., Goate AM; Department of Genetics & Genomic Sciences, Ronald M. Loeb Center for Alzheimer's disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Golbe LI; CurePSP, Inc, New York, New York, USA.; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA., Hansson O; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden., Karch CM; Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA., Kolb HC; Janssen R&D, Neuroscience, San Diego, California, USA., La Joie R; Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA., Lee SE; Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA., Matallana D; Aging Institute, Neuroscience Program, Psychiatry Department, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.; Mental Health Department, Hospital Universitario Fundaciòn Santa Fe, Bogota, Colombia., Miller BL; Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, California, USA., Onyike CU; Division of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, Baltimore, Maryland, USA., Quiroz YT; Departments of Psychiatry and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Rexach JE; Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, University College London Institute of Neurology, Queen Square, London, UK., Rommel A; Rainwater Charitable Foundation, Fort Worth, Texas, USA., Sadri-Vakili G; Sean M. Healey &AMG Center for ALS at Mass General, Massachusetts General Hospital, Boston, Massachusetts, USA., Schindler SE; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA., Schneider JA; Rush Alzheimer's Disease Center, Chicago, Illinois, USA., Sperling RA; Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Teunissen CE; Neurochemistry Laboratory, Clinical Chemistry department, Amsterdam Neuroscience, Program Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Weninger SC; FBRI, Cambridge, Massachusetts, USA., Worley SL; Independent Science Writer, Bryn Mawr, Pennsylvania, USA., Zheng H; Huffington Center on Aging, Baylor College of Medicine, Houston, Texas, USA., Carrillo MC; Alzheimer's Association, Chicago, Illinois, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Mar; Vol. 20 (3), pp. 2240-2261. Date of Electronic Publication: 2024 Jan 03. |
DOI: | 10.1002/alz.13533 |
Abstrakt: | Introduction: The pace of innovation has accelerated in virtually every area of tau research in just the past few years. Methods: In February 2022, leading international tau experts convened to share selected highlights of this work during Tau 2022, the second international tau conference co-organized and co-sponsored by the Alzheimer's Association, CurePSP, and the Rainwater Charitable Foundation. Results: Representing academia, industry, and the philanthropic sector, presenters joined more than 1700 registered attendees from 59 countries, spanning six continents, to share recent advances and exciting new directions in tau research. Discussion: The virtual meeting provided an opportunity to foster cross-sector collaboration and partnerships as well as a forum for updating colleagues on research-advancing tools and programs that are steadily moving the field forward. (© 2024 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.) |
Databáze: | MEDLINE |
Externí odkaz: |